Sagient Research Reports Significant Decline in FDA Drug Approval Rate (PrimeNewswire via Yahoo! Finance)
SAN DIEGO, Jan. 9, 2008 -- Sagient Research Systems, a leading publisher of independent research for the financial services and institutional investment communities, today issued a research report documenting a significant decline in FDA Drug Approvals in 2007.

Pennington Biomedical Research Institute Receives FDA Approval To Begin Phase I Studies Of Compellis Pharmaceuticals' ... (Medical News Today)
Compellis Pharmaceuticals, an early stage biopharmaceutical company developing novel mechanism-based therapeutics for the treatment of obesity, announced that its collaborator Pennington Biomedical Research Institute at Louisiana State University, with Principal Investigator Dr. Frank Greenway, MD, has received FDA approval to begin human clinical Phase I studies.